Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma
about
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.Checkpoint inhibitors in hematological malignanciesImmune checkpoint inhibitors in clinical trialsTetraspanin CD37 protects against the development of B cell lymphomaClinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function.Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.Emerging immune checkpoints for cancer therapy.Targeting the programmed death-1 pathway in lymphoid neoplasms.AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma.B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.Mutations in the signal transducer and activator of transcription family of genes in cancer.Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.Loss of TNFAIP3 enhances MYD88-driven signaling in non-Hodgkin lymphoma
P2860
Q27853399-893995C2-A63B-4D51-B8D0-8B4EB3D2D6D5Q33651495-C9809A4D-9672-4247-BF2E-6274689FB6F1Q34309394-C428694E-CE87-4C2B-9247-090C58F6DFB2Q34509755-E955D22C-0644-45F5-9D54-E77C2B6B9552Q35742367-F67912FD-FDB2-42D9-8FFD-604947357833Q36681461-132B5016-AA6D-48B1-B4BA-A07D4EDE0CEAQ36771814-7CE0E072-78B6-435C-9EB8-9F8C297F9A20Q37109671-7ADC6A33-2775-45E9-9852-E468FABF40AEQ38584979-BAFEEE05-700F-45D7-97C0-3BCDC48F95B6Q39153358-DAC3E178-E75B-42E7-B8CE-11C1877BB03BQ40154948-F9A4CE6C-FADD-4011-B42A-36F9DF160FFFQ40796551-ADEEEDA2-C880-4A9B-97DB-FE045776CCCDQ40834878-39CAD759-7239-41DC-B7C0-97AA53462E2FQ41507351-9EC88EE4-6D25-4183-8575-F1DEDC9E8FFDQ45914413-7A2AE4D6-8B70-4BEC-B507-2119E1034A86Q47422451-AFF8AAEE-12D0-45FB-A264-811525BCF093Q49358927-0A824FC2-060E-4A38-B911-2E6D149C0E7EQ50056654-83C10906-82DB-4DDC-9519-E4E26BDB94D7Q50124900-8C62C2F5-7BCF-4E9E-827D-8916BA6C889DQ55068347-4242AAB2-F585-4309-8AF5-20683341F416Q57287569-CC228C21-4142-46B0-A75A-41EE00E14541
P2860
Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@ast
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@en
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@nl
type
label
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@ast
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@en
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@nl
prefLabel
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@ast
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@en
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@nl
P2093
P2860
P50
P1476
Clinical implications of phosp ...... diffuse large B-cell lymphoma
@en
P2093
Andrés J M Ferreri
April Chiu
Attilio Orazi
Carlo Visco
Eric D Hsi
Jane N Winter
Jiayu Chen
John P Farnen
Jooryung Huh
Karen Dybkær
P2860
P304
P356
10.1158/1078-0432.CCR-14-0683
P407
P50
P577
2014-08-14T00:00:00Z